VVOS icon

Vivos Therapeutics
VVOS

Overview Fund Activity

27 hedge funds and large institutions have $6.66M invested in Vivos Therapeutics in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 7 closing their positions.

Holders
27
Holders Change
-2
Holders Change %
-6.9%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
11
Reduced
6
Closed
7
Calls
$91K
Puts
$126K
Net Calls
-$35K
Net Calls Change
-$53K

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$456K
2
Russell Investments Group
2
Russell Investments Group
United Kingdom
$1.14M
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$540K
4
Group One Trading
4
Group One Trading
Illinois
$180K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.86M

Top Sellers

1
AFM
1
Anson Funds Management
Texas
$0
2
Two Sigma Investments
2
Two Sigma Investments
New York
$0
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$64K
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
Cambridge Investment Research Advisors
5
Cambridge Investment Research Advisors
Iowa
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
AFM
26
Anson Funds Management
Texas
– -$275K -4,892 Closed
Two Sigma Investments
27
Two Sigma Investments
New York
– -$264K -4,689 Closed
Citadel Advisors
28
Citadel Advisors
Florida
– -$59K -1,043 Closed
Cambridge Investment Research Advisors
29
Cambridge Investment Research Advisors
Iowa
– -$43K -768 Closed
UBS Group
30
UBS Group
Switzerland
– -$38K -683 Closed
AIA
31
Avalon Investment & Advisory
Texas
– -$34K -611 Closed
1
2